Sinoway Industrial Co., Ltd.

Celecoxib 169590-42-5 Celecoxib 169590-42-5

Celecoxib 169590-42-5
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

Basic information of Celecoxib:

Name

Celecoxib

CAS NO.

169590-42-5

Molecular Formula

C17H14F3N3O2S

Molecular Weight

381.38

Grade Standard

Medicine grade  / 99% min / USP/ EP / GMP application / PMDA / DMF

Package Size

25kg/drum

Storage:

Keep in a well-closed container, protected from light and stored at a temperature of 2 to 8


Use of Celecoxib: 

Celecoxib is used to relieve the symptoms and signs of osteoarthritis, relieve the symptoms and signs of rheumatoid arthritis, and treat acute pain in adults.

The highest blood concentration was achieved approximately 3 hours after oral administration of a single dose of celecoxib. In the fasting state, when the dose of celecoxib is as high as 200mg twice daily, the highest blood concentration (Cmax) and the area under the curve (AUC) are roughly proportional to the dose; when the dose is increased, this proportional relationship Weaken (see food effects). At present, no studies have been conducted on absolute bioavailability. Steady-state plasma levels can be reached within 5 days after multiple doses.

COA of Celecoxib :


COA of Celecoxib

* Products under the patent are only for R&D use.

  • Sodium Azulene Sulfonate 6223-35-4
    Basic information of Sodium Azulene Sulfonate:NameSodium Azulene SulfonateAliasSodium 1,4-dimethyl-7-isopropylazulene-3-sulfonateCAS NO.6223-35-4Molecular FormulaC15H17NaO3S・1/2H2O C15H17NaO3S・H2OQu... Sodium Azulene Sulfonate 6223-35-4
  • Pitavastatin Calcium 147526-32-7
    Basic information of Pitavastatin Calcium :NamePitavastatincalciumCAS :147526-32-7Molecular FormulaC50H46CaF2N2O8Molecular Weight880.98Quality StandardIn-house Standard, Assay: >99.0% Package Size... Pitavastatin Calcium 147526-32-7
  • Febuxostat 144060-53-7
    Basic information of FebuxostatNameFebuxostatAlias2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic AcidCAS Number144060-53-7Molecular FormulaC16H16N2O3SMolecular Weight316.37Quality... Febuxostat 144060-53-7
  • Imatinib Mesylate 220127-57-1
    Basic information of Imatinib Mesylate:NameImatinib MesylateAliasGLIVEC;GLEEVEC;IMATINIB METHANESULFONATE; CGP-57148B; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)a... Imatinib Mesylate 220127-57-1

MORE_DETAIL Celecoxib 169590-42-5

Basic information of Celecoxib:

Name

Celecoxib

CAS NO.

169590-42-5

Molecular Formula

C17H14F3N3O2S

Molecular Weight

381.38

Grade Standard

Medicine grade  / 99% min / USP/ EP / GMP application / PMDA / DMF

Package Size

25kg/drum

Storage:

Keep in a well-closed container, protected from light and stored at a temperature of 2 to 8


Use of Celecoxib: 

Celecoxib is used to relieve the symptoms and signs of osteoarthritis, relieve the symptoms and signs of rheumatoid arthritis, and treat acute pain in adults.

The highest blood concentration was achieved approximately 3 hours after oral administration of a single dose of celecoxib. In the fasting state, when the dose of celecoxib is as high as 200mg twice daily, the highest blood concentration (Cmax) and the area under the curve (AUC) are roughly proportional to the dose; when the dose is increased, this proportional relationship Weaken (see food effects). At present, no studies have been conducted on absolute bioavailability. Steady-state plasma levels can be reached within 5 days after multiple doses.

COA of Celecoxib :


COA of Celecoxib

* Products under the patent are only for R&D use.
Leave a Message Email Us

We will contact you within 24 hours.

  • TEL:+86-0592-5853819
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//